-
1 Comment
Motus GI Holdings, Inc is currently in a long term downtrend where the price is trading 12.6% below its 200 day moving average.
From a valuation standpoint, the stock is 70.6% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 393.3.
Motus GI Holdings, Inc's total revenue sank by 63.6% to $36K since the same quarter in the previous year.
Its net income has increased by 25.9% to $-4M since the same quarter in the previous year.
Finally, its free cash flow grew by 44.4% to $-3M since the same quarter in the previous year.
Based on the above factors, Motus GI Holdings, Inc gets an overall score of 3/5.
Exchange | OTCQB |
---|---|
CurrencyCode | USD |
Sector | Healthcare |
ISIN | US62014P1084 |
Industry | Medical Devices |
Beta | 0.28 |
---|---|
Market Cap | 639 |
PE Ratio | None |
Target Price | 8.3 |
Dividend Yield | None |
Motus GI Holdings, Inc. operates as a medical technology company in the United States. It develops Pure-Vu system, a medical device to facilitate the cleansing of a poorly prepared gastrointestinal tract during the colonoscopy and facilitates upper gastrointestinal endoscopy procedures. The company was formerly known as Eight-Ten Merger Corp. and changed its name to Motus GI Holdings, Inc. in November 2016. The company was founded in 2008 and is based in Fort Lauderdale, Florida.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for MOTS using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025